Job title: Senior Lecturer in Pharmacology and Pharmacy Practice

I am a pharmacist with an established research profile in cardiovascular health and disease. I have been Senior Lecturer in Pharmacology and Pharmacy Practice at Liverpool John Moores University since 2009. In 2016 I was appointed as Editor in Chief of 'Autonomic and Autacoid Pharmacology'

My research interests include investigating clinical outcomes in cardiovascular disease, with a particular focus on hypertension, dyslipidaemias and ischaemia-reperfusion injury. I am primarily involved in meta-analysis and clinical trials. In this work I am lucky to work with many international experts in the Lipid and Blood Pressure Meta Analysis Collaboration http://lbpmcgroup.umed.pl . I employ a range of research methods in the laboratory in addition to my interest in meta analysis.

I am the author of several research papers and textbook chapters. I have conducted research at Cardiff University (UK), University of Surrey (UK), and the University of Regensburg (Germany).

I am registered as a pharmacist with the General Pharmaceutical Council (UK). I am a member of The British Pharmacological Society, The International Society for Heart Research, The British Society for Heart Failure, The British Society for Cardiovascular Research and the Royal Pharmaceutical Society. I am a Fellow of the Higher Education academy.

Teaching Responsibilities

I teach cardiovascular physiology, pharmacology and therapeutics on the MPharm. programme. As a pharmacist, I am also involved in teaching Pharmacy Practice elements of the course. I have responsibility for undergraduate and postgraduate masters projects in addition to supervising PhD candidates.

Administrative Responsibilities:

Module Group Leader: Scientific Basis of Therapeutics Module Leader: 'The Scientific Basis of Therapeutics 3' M.Pharm L6 (36 Credits) Module Development Leader: 'Complexities of Healthcare' M.Pharm L6 (120 Credits)

Degrees

2009, Cardiff University, United Kingdom, Ph.D. 2004, University of Wales, United Kingdom, M.Pharm.

Penson P, McGowan M, Banach M. 2017. Evaluating bempedoic acid for the treatment of hyperlipidaemia Expert Opinion on Investigational Drugs, >DOI Brie D, Sahebkar A, Penson P, Dinca M, Ursoniu S, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Effects of Pentoxifylline on Inflammatory Markers and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Journal of Hypertension, >DOI Kotani K, Serban M-C, Penson P, Lippi G, Banach M. 2016. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – some answers and still many questions Critical Reviews in Clinical Laboratory Sciences, :1-28 >DOI Brie D, Penson P, Serban M-C, Toth PP, Simonton C, Serruys PW, Banach M. 2016. Bioresorbable scaffold — A magic bullet for the treatment of coronary artery disease? International Journal of Cardiology, 215 :47-59 >DOI Dinca M, Serban M-C, Sahebkar A, Mikhailidis DP, Toth PP, Martin SS, Blaha MJ, Blüher M, Gurban C, Penson P, Michos ED, Hernandez AV, Jones SR, Banach M. 2016. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials Pharmacological Research, 107 :360-371 >DOI Penson P, McGowan M, Banach M. 2017. Evaluating bempedoic acid for the treatment of hyperlipidaemia Expert Opinion on Investigational Drugs, >DOI Penson P, Serban M-C, Ursoniu S, Banach M. 2017. DOES COFFEE CONSUMPTION ALTER PLASMA LIPOPROTEIN(A) CONCENTRATIONS? A SYSTEMATIC REVIEW. Critical Reviews in Food Science and Nutrition, >DOI Awad K, Penson P, Banach M. 2016. D-003 (Saccharum officinarum): The forgotten lipid-lowering agent Pharmacological Research, 114 :42-46 >DOI Brie D, Sahebkar A, Penson P, Dinca M, Ursoniu S, Serban M-C, Zanchetti A, Howard G, Ahmed A, Aronow WS, Muntner P, Lip GYH, Wong ND, Rysz J, Banach M. 2016. Effects of Pentoxifylline on Inflammatory Markers and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Journal of Hypertension, >DOI Kotani K, Serban M-C, Penson P, Lippi G, Banach M. 2016. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – some answers and still many questions Critical Reviews in Clinical Laboratory Sciences, :1-28 >DOI Brie D, Penson P, Serban M-C, Toth PP, Simonton C, Serruys PW, Banach M. 2016. Bioresorbable scaffold — A magic bullet for the treatment of coronary artery disease? International Journal of Cardiology, 215 :47-59 >DOI Dinca M, Serban M-C, Sahebkar A, Mikhailidis DP, Toth PP, Martin SS, Blaha MJ, Blüher M, Gurban C, Penson P, Michos ED, Hernandez AV, Jones SR, Banach M. 2016. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials Pharmacological Research, 107 :360-371 >DOI Penson PE. 2012. Lecturing: A lost art Currents in Pharmacy Teaching and Learning, 4 :72-76 >DOI Broadley KJ, Davies RH, Escargueil C, Lee ATL, Penson P, Thomas EJ. 2011. SYNTHESIS OF ANTAGONISTS OF MUSCARINIC (M-3) RECEPTORS COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 76 :781-801 >DOI >Link Penson PE, Ford WR, Kidd EJ, Broadley KJ. 2008. Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn Schmiedebergs Arch Pharmacol, 378 :589-597 >DOI >Link Penson PE, Ford WR, Broadley KJ. 2007. Vasopressors for cardiopulmonary resuscitation. Does pharmacological evidence support clinical practice? Pharmacol Ther, 115 :37-55 >DOI >Link Broadley KJ, Penson PE. 2006. Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties. Eur J Pharmacol, 536 :279-286 >DOI >Link Broadley KJ, Penson PE. 2004. The roles of alpha- and beta-adrenoceptor stimulation in myocardial ischaemia. Auton Autacoid Pharmacol, 24 :87-93 >DOI >Link Penson PE. 2016. Autonomic & Autacoid Pharmacology 2016: The year in review. Auton Autacoid Pharmacol, 36 :27-27 >DOI >Link Penson P. 2016. Autonomic & Autacoid Pharmacology: past, present and future Autonomic and Autacoid Pharmacology, >DOI Penson PE. 2009. Incense - A problematic method of drug-delivery. Med Hypotheses, 72 :482 >DOI >Link Penson P. 2007. Peter Penson on one way to cut the NHS drugs budget The Health service journal, Penson PE. 2006. Wasted journey [15] Pharmaceutical Journal, 276 :322 Penson PE. 2005. Academic rigour? [9] Pharmaceutical Journal, 275 :752 Penson P. 2004. Apply liberally [12] Pharmaceutical Journal, 273 :644